Not applicableUnknownNCT03381326
What this trial is testing
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.
Who this might be right for
Prostate CancerMetastatic CancerCastration-resistant Prostate Cancer+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 104